Drug intelligence / Profile preview

sodium chloride + calcium chloride + dextrose monohydrate + sodium lactate + magnesium chloride

Development stage
Approved
Lead developer
Fresenius Medical Care
Modality
Small Molecules
Administration
Intraperitoneal
01

Overview

sodium chloride + calcium chloride + dextrose monohydrate + sodium lactate + magnesium chloride is a multi-component peritoneal dialysis solution used for renal replacement therapy in patients with renal failure requiring peritoneal dialysis. It is marketed in products such as Delflex and Dianeal. Dextrose monohydrate functions as the osmotic agent that creates a transperitoneal osmotic gradient to promote ultrafiltration and fluid removal, while sodium, calcium, magnesium, and chloride provide electrolyte content and sodium lactate serves as a metabolizable buffer that helps correct acid-base abnormalities. This product is not a targeted small molecule or biologic; its therapeutic effect is primarily physicochemical within the peritoneal cavity rather than mediated by a discrete molecular target.

Brand names
DelflexDianeal
Other names
peritoneal dialysis solutionlactate-buffered dextrose peritoneal dialysis solutionhypertonic peritoneal dialysis solution

Beyond the preview

Go deeper on sodium chloride + calcium chloride + dextrose monohydrate + sodium lactate + magnesium chloride.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on sodium chloride + calcium chloride + dextrose monohydrate + sodium lactate + magnesium chloride.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call